PureHealth H1 2026: $326.75M Profit, $4.06bn Revenue Validates GCC Healthcare Non-Oil Growth
PureHealth's results validate the non-oil diversification thesis for UAE equity allocation. Healthcare demand in the GCC is structurally driven by population growth, medical tourism, and insurance mandates—none of which are oil-price correlated. ADX healthcare names offer the closest thing to non-cyclical exposure in the Gulf equity universe. ADIA and Mubadala's continued healthcare infrastructure thesis is being validated in public-market P&L, a positive signal for Vision 2030 diversification credibility.
Read at Economy Middle East ↗